A Win For Plus Therapeutics, Inc.

Plus Therapeutics, Inc. (PSTV:NASDAQ) rocketted at $0.32, a gain of 68.4%. On Wed, Jun 25, 2025, PSTV:NASDAQ hit a New 2-Week Intraday High of $0.44. The stock got featured on our News Catalysts scanner on Wed, Jun 25, 2025 at 06:30 PM in the 'INVESTOR UPDATE' category. From Wed, Jun 11, 2025, the stock recorded 22.22% Up Days and 20.00% Green Days

The stock spiked on Wed, Jun 25, 2025 at $0.44 with a volume of 705M+.

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.